Related Experiment Video
Updated: Apr 21, 2026

In vitro Organoid Culture of Primary Mouse Colon Tumors
Published on: May 17, 2013
hARIP2 is a putative growth-promoting factor involved in human colon tumorigenesis
Rui-Feng Gao1, Zhan-Dong Li, Jing Jiang
1Changchun University of Science and Technology, Changchun, China E-mail : nszhang9@sina.com, hltiet@163.com, rumeng2215137@163.com.
Abstract:
Activin is a multifunctional growth and differentiation factor of the growth factor-beta (TGF-β) superfamily, which inhibits the proliferation of colon cancer cells. It induces phosphorylation of intracellular signaling molecules (Smads) by interacting with its type I and type II receptors. Previous studies showed that human activin receptor-interacting protein 2 (hARIP2) can reduce activin signaling by interacting with activin type II receptors; however, the activity of hARIP2 in colon cancer has yet to be detailed. In vitro, overexpression of hARIP2 reduced activin-induced transcriptional activity and enhanced cell proliferation and colony formation in human colon cancer HCT8 cells and SW620 cells. Also, hARIP2 promoted colon cancer cell apoptosis, suggesting that a vital role in the initial stage of colon carcinogenesis. In vivo, immunohistochemistry revealed that hARIP2 was expressed more frequently and much more intensely in malignant colon tissues than in controls. These results indicate that hARIP2 is involved in human colon tumorigenesis and could be a predictive maker for colon carcinoma aggressiveness.
Insights
Human activin receptor-interacting protein 2 (hARIP2) promotes colon cancer growth and is highly expressed in malignant tissues. This suggests hARIP2 may be a predictive marker for colon carcinoma aggressiveness.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Activin, a TGF-β superfamily member, inhibits colon cancer cell proliferation.
- Human activin receptor-interacting protein 2 (hARIP2) negatively regulates activin signaling.
- The role of hARIP2 in colon cancer remains underexplored.
Purpose of the Study:
- To investigate the role and significance of hARIP2 in human colon cancer.
Main Methods:
- In vitro studies using colon cancer cell lines (HCT8, SW620) with hARIP2 overexpression.
- In vivo analysis using immunohistochemistry on human colon tissues.
Main Results:
- hARIP2 overexpression reduced activin signaling, enhanced cell proliferation, and colony formation in vitro.
- hARIP2 promoted colon cancer cell apoptosis, indicating a role in early carcinogenesis.
- hARIP2 expression was significantly higher in malignant colon tissues compared to controls.
Conclusions:
- hARIP2 plays a role in human colon tumorigenesis.
- hARIP2 expression levels may serve as a predictive marker for colon carcinoma aggressiveness.
More Related Videos
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Mitogens and the Cell Cycle
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression
Abnormal Proliferation
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...

